70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Emiel J. Rutgers, Peter Vuylsteke et al.|The Lancet Oncology|2021Cited by 355
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancerFrancesco Schettini, Daniele Generali, Sergio Venturini et al.|Cancer Treatment Reviews|2022Cited by 35
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast CancerFrancesco Schettini, Daniele Generali, Mario Giuliano et al.|Cancers|2021Cited by 19